Regen BioPharma, Inc.
RGBP · OTC
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Market Cap | $1,188 | $1,078 | $578 | $422 |
| - Cash | $2 | $2 | $0 | $1 |
| + Debt | $1,036 | $968 | $873 | $794 |
| Enterprise Value | $2,222 | $2,044 | $1,451 | $1,215 |
| Revenue | $59 | $59 | $59 | $59 |
| % Growth | 0% | 0% | -0.5% | – |
| Gross Profit | $59 | $59 | $59 | $59 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$130 | $16 | -$423 | -$326 |
| % Margin | -220.1% | 26.4% | -716.2% | -549.6% |
| Net Income | -$167 | -$19 | -$515 | -$265 |
| % Margin | -283.2% | -32.8% | -871.9% | -446.2% |
| EPS Diluted | -0.007 | -0.001 | -0.065 | -0.064 |
| % Growth | -677.8% | 98.6% | -2.4% | – |
| Operating Cash Flow | -$56 | -$101 | -$66 | -$149 |
| Capital Expenditures | -$0 | $0 | $0 | -$0 |
| Free Cash Flow | -$56 | -$101 | -$66 | -$149 |